Status:

NOT_YET_RECRUITING

Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation

Lead Sponsor:

Wei Gao

Conditions:

Immune Tolerance

Immunosuppression

Eligibility:

All Genders

4+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn about the efficacy and safety of immunosuppressive withdrawal in pediatric liver transplant recipients. The main question it aims to answer is:exploring the...

Detailed Description

Background: The main conditions which require pediatric liver transplantation are benign diseases with curable primary diseases, such as metabolic and biliary diseases. After liver transplantation, th...

Eligibility Criteria

Inclusion

  • Age at liver transplantation: under 6 years
  • Follow-up time after liver transplantation: more than 4 years
  • Liver function maintains normal before enrollment
  • Monotherapy of IS (Tacrolimus or Cyclosporine A)
  • Liver biopsy: No signs of acute rejection or chronic rejection, and no obvious fibrosis (Ishak\<2) 2 years before enrollment
  • Female recipients of fertility treatment must have a negative pregnancy test before enrollment
  • No Hepatitis virus infection 1 year before enrollment
  • Written consents are required

Exclusion

  • Original disease before liver transplantation: Tumor, secondary liver transplantation, hepatitis virus infection, autoimmune hepatitis
  • Type of liver transplantation: ABO incompatible liver transplantation or multiple organ transplantation
  • Liver biopsy: obvious fibrosis(Ishak≥2;LAFSc moderate or severe)
  • Recipients taking IS for other diseases besides their liver transplantation

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2028

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT06147375

Start Date

December 1 2023

End Date

December 1 2028

Last Update

November 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin First Central Hospital

Tianjin, Tianjin Municipality, China, 300192